UBS ASSET MANAGEMENT AMERICAS LLC - HOMOLOGY MEDICINES INC ownership

HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 107 filers reported holding HOMOLOGY MEDICINES INC in Q1 2022. The put-call ratio across all filers is 4.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of HOMOLOGY MEDICINES INC
ValueSharesWeighting
Q1 2022$199,196,000
-16.5%
65,5250.0%0.00%
Q4 2021$238,512,000
-57.6%
65,525
-8.3%
0.00%
Q3 2021$562,525,000
-4.4%
71,477
-11.7%
0.00%
Q2 2021$588,172,000
+76.1%
80,904
+127.9%
0.00%
Q1 2021$334,055,000
+5.7%
35,500
+26.8%
0.00%
Q4 2020$316,120,000
+85.8%
28,000
+76.1%
0.00%
Q3 2020$170,130,000
-10.4%
15,900
+27.2%
0.00%
Q2 2020$189,875,000
+12.1%
12,500
+14.7%
0.00%
Q1 2020$169,386,000
-24.9%
10,9000.0%0.00%
Q4 2019$225,630,00010,9000.00%
Other shareholders
HOMOLOGY MEDICINES INC shareholders Q1 2022
NameSharesValueWeighting ↓
5AM Venture Management, LLC 4,535,919$8,936,0002.21%
Vida Ventures Advisors, LLC 770,845$1,519,0001.28%
OUP Management Co., LLC 64,000$126,0000.17%
Oasis Management Co Ltd. 280,000$552,0000.10%
Vivo Capital, LLC 370,068$729,0000.07%
AAF Wealth Management, LLC 47,501$94,0000.07%
TANG CAPITAL MANAGEMENT LLC 214,898$423,0000.06%
Temasek Holdings (Private) Ltd 5,650,996$11,132,4620.06%
Bellevue Group AG 1,622,522$3,196,0000.04%
GSA CAPITAL PARTNERS LLP 128,353$253,0000.04%
View complete list of HOMOLOGY MEDICINES INC shareholders